SynthesisFrontiers in oncology2024

Efficacy and safety of Toliparibumab for the treatment of non-small cell lung cancer: a systematic review and meta-analysis.

Yihao Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.